Vasogin (VAS-T) Stock Predictions - Stockchase
WATCH LIST
34
Vasogin (VAS-T)

ON STOCKCHASE SINCE Nov 2000

autoimmune disorders such as asthma

biotechnology/pharmaceutical

Vasogin

VAS-T

0 watching          
Join the Discussion

Vasogin (VAS-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about VAS-T



  • All
  • Filtered
Signal Opinion Expert
DON'T BUY
Vasogin(VAS-T) 

April 19, 2007

When a biotech finds the right thing, the stock can jump like crazy. This company just had a 1 for 10 reverse split. 90% of companies that do a reverse split are still down one year later.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
When a biotech finds the right thing, the stock can jump like crazy. This company just had a 1 for 10 reverse split. 90% of companies that do a reverse split are still down one year later.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Benj Gallander

President, Contra the Heard Inv...

Price Price
$4.500
Owned Owned
No

DON'T BUY
Vasogin(VAS-T) 

February 21, 2007

This one is past the point of no return. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
This one is past the point of no return. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Larry Berman CF

Chief Inve, ETF Capital Manageme...

Price Price
$0.430
Owned Owned
No

PAST TOP PICK
Vasogin(VAS-T) 

January 17, 2005

(Top Short Sept 8/04. Sold in low $5's so he's ahead about 19%.)

biotechnology/pharmaceutical
0 0 0 0 0
0 comments

(Top Short Sept 8/04. Sold in low $5's so he's ahead about 19%.)

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew McCreath

Senior Por, Sentry Select Capita...

Price Price
$6.160
Owned Owned
No

BUY
Vasogin(VAS-T) 

January 7, 2005

Have been building up their balance sheet to complete their final trials. Are now approaching a critical time. Feels the company can start to look better from here.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have been building up their balance sheet to complete their final trials. Are now approaching a critical time. Feels the company can start to look better from here.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$6.450
Owned Owned
Yes

TOP PICK
Vasogin(VAS-T) 

September 8, 2004

Top Short Doesn't feel they have a lot of R&D to show. Have a lot of cash on the books.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Top Short Doesn't feel they have a lot of R&D to show. Have a lot of cash on the books.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew McCreath

Senior Por, Sentry Select Capita...

Price Price
$6.500
Owned Owned
No

BUY
Vasogin(VAS-T) 

March 24, 2004

Interesting technology.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Interesting technology.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ed Ho

Portfolio , Dynamic Mutual Funds...

Price Price
$7.600
Owned Owned
No

HOLD
Vasogin(VAS-T) 

January 23, 2004

Have signed on with a bigger company and now have to wait for the revenues and earnings to kick in. Easy money has been made.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have signed on with a bigger company and now have to wait for the revenues and earnings to kick in. Easy money has been made.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$8.980
Owned Owned
No

DON'T BUY
Vasogin(VAS-T) 

December 16, 2003

They are risk model on bile tax turned negative a couple of months ago so they sold their holdings. Well-run and has an interesting product. They are in the process of being listed in the US. Wait for some strength in that sector.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
They are risk model on bile tax turned negative a couple of months ago so they sold their holdings. Well-run and has an interesting product. They are in the process of being listed in the US. Wait for some strength in that sector.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Burrows

President , Barometer Capital Ma...

Price Price
$7.470
Owned Owned
No

DON'T BUY
Vasogin(VAS-T) 

November 20, 2003

Have no earnings and won’t for the next 3 years. Model price is $1.50.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have no earnings and won’t for the next 3 years. Model price is $1.50.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$6.750
Owned Owned
No

DON'T BUY
Vasogin(VAS-T) 

September 26, 2003

Prefers companies with consistent earnings. Too speculative for them.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Prefers companies with consistent earnings. Too speculative for them.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jonathen Wellum

Chief Exec, AIC Limited...

Price Price
$7.980
Owned Owned
No

WEAK BUY
Vasogin(VAS-T) 

May 12, 2003

Looks like some one is accumulating it. Well run. A little expensive now.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Looks like some one is accumulating it. Well run. A little expensive now.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$5.800
Owned Owned
Unknown

STRONG BUY
Vasogin(VAS-T) 

April 10, 2003

Bullish on the stock. 2 trials are in phase 3. Good cash position.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bullish on the stock. 2 trials are in phase 3. Good cash position.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$4.800
Owned Owned
Unknown

WEAK BUY
Vasogin(VAS-T) 

April 1, 2003

Interesting technology. Sector is doing well. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Interesting technology. Sector is doing well. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Burrows

President , Barometer Capital Ma...

Price Price
$3.950
Owned Owned
Unknown

BUY
Vasogin(VAS-T) 

March 3, 2003

Looking at a number of phase 3 trials. Good management.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Looking at a number of phase 3 trials. Good management.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$4.230
Owned Owned
Unknown

HOLD
Vasogin(VAS-T) 

October 10, 2002

They have done what they said they would.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
They have done what they said they would.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$2.800
Owned Owned
Unknown

Showing 1 to 15 of 34 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days